Congenital Hypothyroidism With Eutopic Thyroid Gland: Analysis of Clinical and Biochemical Features at Diagnosis and After Re-Evaluation
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
CONTEXT: In recent years changes in screening strategies for congenital hypothyroidism (CH) led to an increased detection of mild forms of CH, associated with eutopic thyroid gland. OBJECTIVES: We aimed to determine the clinical evolution of CH with eutopic thyroid gland and to find out prognostic factors at diagnosis and follow-up. PATIENTS AND METHODS: We retrospectively analyzed a group of 84 children with CH and eutopic thyroid gland treated at our institution. They all underwent clinical re-evaluation after the age of 3, based on thyroid function testing after l-thyroxine therapy withdrawal, thyroid ultrasonography, and (123)I scintigraphy with perchlorate discharge test. Genetic analysis was performed in selected cases. RESULTS: At re-evaluation, 34.5% of patients showed permanent hypothyroidism and needed l-thyroxine reintroduction, 27.4% had persistent hyperthyrotropinemia (TSH 5-10 mU/L), and 38.1% had transient hypothyroidism. Major risk factors for permanent CH were prematurity, first-degree familial history of goiter/nodules, thyroid hypoplasia at diagnosis, and high l-thyroxine requirements at follow-up. Iodine organification defects were found in 29.7% of patients, 30% of whom harbored DUOX2 mutations. TSH receptor gene mutations were found in 8.7% of patients with persistent thyroid dysfunction and negative perchlorate discharge test. CONCLUSIONS: Only one-third of patients with CH and eutopic thyroid gland needed to continue l-thyroxine therapy after re-evaluation. A frequent finding was the persistence of mild hyperthyrotropinemia. The evolution of CH remains difficult to predict, although different clinical features might suggest different outcomes. Mutations in the genes commonly linked to mild forms of CH were documented in a minority of cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirement at 1 to 3 years of age are associated with permanent CH”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Increase in congenital hypothyroidism in New York State and in the United States
Harris, K. B., & Pass, K. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.012 · Cited by 270 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundSelf-citationDeladoëy, J., Ruel, J., Giguère, Y., & Van Vliet, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1073 · Cited by 235
Grosse, S. D., & Van Vliet, G. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.190280 · Cited by 222
Hinton, C. F., Harris, K. B., Borgfeld, L., Drummond-Borg, M., Eaton, R., Lorey, F., Therrell, B. L., Wallace, J., & Pass, K. A. (2010) · Pediatrics · doi:10.1542/peds.2009-1975d · Cited by 207
Mengreli, C., Kanaka-Gantenbein, C., Girginoudis, P., Magiakou, M.-A., Christakopoulou, I., Giannoulia-Karantana, A., Chrousos, G. P., & Dacou-Voutetakis, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0057 · Cited by 146 · cited 1×
“In particular, an increased incidence was documented in Italy (1:2200 according to the Italian National Registry of Infants with CH [3]; 1:1446 in Lombardy region [4], 1:1749 in Greece [5], 1:1660 in Massachusetts, USA [6]; 1:1415 in New York, USA [7], and 1:1077 in the United Kingdom [8]).”
BackgroundGaudino, R., Garel, C., Czernichow, P., & Léger, J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02239.x · Cited by 138
Research works printed but not linked: 1
- 15. KrudeH,BlankensteinO. Treatingpatientsnotnumbers:thebenefit and burden of lowering TSH newborn screening cut-offs. Arch Dis Child . 2011;96:121-122.
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“In contrast, factors such as prematurity (11,142,143), other congenital abnormalities (141), a family history of thyroid disease (142), abnormal thyroid morphology (thyroid hypoplasia at diagnosis) (142), TSH elevation >10 mU/L after the age of 1 year (when infants outgrow the LT4 dose), and a higher LT4 dose requirem…”
BackgroundSelf-citationTreatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Thyroid Disorders in Children and Adolescents: A Review
Hanley, P., Lord, K., & Bauer, A. J. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.0486 · Cited by 237
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
Wassner, A. J. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2017.10.004 · Cited by 165
Subclinical hypothyroidism in childhood — current knowledge and open issues
Salerno, M., Capalbo, D., Cerbone, M., & Luca, F. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.100 · Cited by 141
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Congenital hypothyroidism: recent advances
Wassner, A. J., & Brown, R. S. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000181 · Cited by 120
Nicholas, A. K., Serra, E. G., Cangul, H., Alyaarubi, S., Ullah, I., Schoenmakers, E., Deeb, A., Habeb, A. M., Almaghamsi, M., Peters, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1879 · Cited by 112
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“Similarly, the prevalence of DUOX2 variants in Italy has been reported as 15% in unselected patients with congenital hypothyroidism, 23% in those with a eutopic thyroid gland [23], and to 30–37% in those with a eutopic gland and a documented partial iodine organification disorder [24, 25].”
BackgroundEvolution of Thyroid Function in Preterm Infants Detected by Screening for Congenital Hypothyroidism
Vigone, M. C., Caiulo, S., Frenna, M. D., Ghirardello, S., Corbetta, C., Mosca, F., & Weber, G. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.12.048 · Cited by 107
Self-citationPediatric Hypothyroidism: Diagnosis and Treatment
Wassner, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0238-0 · Cited by 116
“In patients with a eutopic thyroid gland, the degree of TSH elevation at diagnosis is not predictive of disease permanence, but patients who require\2 lg/kg of LT4 daily are more likely to have transient disease [47].”
BackgroundThe molecular causes of thyroid dysgenesis: a systematic review.
Nettore, I. C., Cacace, V., Fusco, C. D., Colao, A., & Macchia, P. E. (2013) · PubMed · doi:10.3275/8973 · Cited by 81
“7% of the studied cases a mutation in TSHR gene has been identified (3).”
BackgroundLéger, J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0777 · Cited by 72
Díaz, A., & Diaz, E. G. L. (2014) · Pediatrics in Review · doi:10.1542/pir.35.8.336 · Cited by 65
Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism
Bauer, A. J., & Wassner, A. J. (2019) · Endocrine · doi:10.1007/s12020-019-02024-6 · Cited by 69
Predictors of transient congenital hypothyroidism in children with eutopic thyroid gland
Park, I. S., Yoon, J. S., So, C. H., Lee, H. S., & Hwang, J. S. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.2.115 · Cited by 57
Messina, M. F., Aversa, T., Salzano, G., Zirilli, G., Sferlazzas, C., De Luca, F., & Lombardo, F. (2015) · Hormone Research in Paediatrics · doi:10.1159/000435811 · Cited by 55
MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children
Salerno, M., Improda, N., & Capalbo, D. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0051 · Cited by 62
Permanent vs Transient Congenital Hypothyroidism: Assessment of Predictive Variables
Oron, T., Lazar, L., Ben-Yishai, S., Tenenbaum, A., Yackobovitch-Gavan, M., Meyerovitch, J., Phillip, M., & Lebenthal, Y. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00362 · Cited by 54
“The higher prevalence of CH with a eutopic thyroid gland (4, 14) may stem from increased screening of patients at higher risk (those with very low birth weight or premature infants), a higher detection rate, and the introduction of progressively lower TSH cutoffs (16–18).”
BackgroundResultTransient Congenital Hypothyroidism in Turkey: An Analysis on Frequency and Natural Course
Kara, C., Günindi, F., Can Yılmaz, G., & Aydın, M. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2345 · Cited by 53
Saba, C., Guilmin-Crepon, S., Zénaty, D., Martinerie, L., Paulsen, A., Simon, D., Storey, C., Dos Santos, S., Haignere, J., Mohamed, D., et al. (2018) · Thyroid · doi:10.1089/thy.2018.0154 · Cited by 51
“Over the last 15 years, the prevalence of transient hypothyroidism detected through newborn screening programs has been re-ported to range between 17% and 65% (4,11,14–17, 19, The etiology of CH with a eutopic gland remains elusive, and the factors driving its clinical diversity are largely unknown.”
Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
Vigone, M. C., Capalbo, D., Weber, G., & Salerno, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00471 · Cited by 51
Self-citationKang, M.-J., Chung, H.-R., Oh, Y.-J., Shim, Y.-S., Yang, S., & Hwang, I.-T. (2017) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2017.01.002 · Cited by 45
Tuli, G., Munarin, J., Tessaris, D., Matarazzo, P., Einaudi, S., & SANCTIS, L. D. (2020) · Endocrine · doi:10.1007/s12020-020-02370-w · Cited by 48
MECHANISMS IN ENDOCRINOLOGY: The pathophysiology of transient congenital hypothyroidism
Peters, C. J., & Schoenmakers, N. A. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1278 · Cited by 50
“A smaller number of studies have specifically evaluated the proportion of CH attributable to TCH, with most demonstrating an increase over time, such that this may now include more than one-third of children with GIS CH (6, 7, 16).”
Maruo, Y., Nagasaki, K., Matsui, K., Mimura, Y., Mori, A., Fukami, M., & Takeuchi, Y. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0959 · Cited by 46
“Recent reports have shown that a high proportion of CH cases are 77 caused by mutations in hormone-producing enzymes, and DUOX2 mutations are one of the most 78 frequent causes (13-16).”
BackgroundHypothyroidism in the newborn period
Wassner, A. J., & Brown, R. S. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000433063.78799.c2 · Cited by 44
DUOX Defects and Their Roles in Congenital Hypothyroidism
Deken, X. D., & Miot, F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_37 · Cited by 44
Cho, M. S., Cho, G. S., Park, S. H., Jung, M. H., Suh, B. K., & Koh, D. G. (2014) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2014.19.3.141 · Cited by 40
Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism
Park, E. S., & Yoon, J. Y. (2019) · BMC Pediatrics · doi:10.1186/s12887-019-1833-8 · Cited by 44
Zdraveska, N., Zdravkovska, M., Anastasovska, V., Sukarova-Angelovska, E., & Kocova, M. (2018) · Endocrine Connections · doi:10.1530/ec-17-0332 · Cited by 37
Congenital hypothyroidism: current perspectives
Dayal, D., & Anne, R. P. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s56402 · Cited by 40
“On reevaluation, an almost equal proportion of patients may show TH, permanent CH, or persistent hyperthyrotropinemia.(11,50) Many of these cases may have iodine organification defects, DUOX2 mutations, or TSH resistance.”
BackgroundFu, C., Luo, S., Li, Y., Li, Q., Hu, X., Li, M., Zhang, Y., Su, J., Hu, X., Chen, Y., et al. (2017) · Endocrine Connections · doi:10.1530/ec-17-0289 · Cited by 35
Marr, A., Yokubynas, N., Tang, K., Saleh, D. S., Wherrett, D. K., Stein, R., Bassilious, E., Chakraborty, P. K., & Lawrence, S. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab798 · Cited by 36
Jiang, H., Wu, J., Ke, S., Hu, Y., Fei, A., Zhen, Y., Yu, J. S., & Zhu, K. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.07.004 · Cited by 34
Neonatal Screening for Congenital Hypothyroidism: What Can We Learn From Discordant Twins?
Medda, E., Vigone, M. C., Cassio, A., Calaciura, F., Costa, P., Weber, G., de Filippis, T., Gelmini, G., Frenna, M. D., Caiulo, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00900 · Cited by 34
Self-citationMild TSH resistance: Clinical and hormonal features in childhood and adulthood
Vigone, M. C., Di Frenna, M., Guizzardi, F., Gelmini, G., de Filippis, T., Mora, S., Caiulo, S., Sonnino, M., Bonomi, M., Persani, L., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13387 · Cited by 28
Self-citationDiagnosing and managing dementia patients. Practice patterns of family physicians.
Cheok, A., Cohen, C. A., & Sarracini, C. Z. (1997) · PubMed · Cited by 29
Jung, J. M., Jin, H. Y., & Chung, M. L. (2016) · Hormone Research in Paediatrics · doi:10.1159/000443399 · Cited by 28
Diagnosis, Treatment and Outcome of Congenital Hypothyroidism
Van Vliet, G., & Deladoëy, J. (2014) · Endocrine Development · doi:10.1159/000363155 · Cited by 28
Satoh, M., Aso, K., Ogikubo, S., Yoshizawa-Ogasawara, A., & Saji, T. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0078 · Cited by 27
Zhou, J., Luo, J., Lin, J., Zeng, Y., Qiu, X., Zhu, W., & Liu, G. (2020) · Medicine · doi:10.1097/md.0000000000020838 · Cited by 32
“[38] However, other studies have shown no difference in the confirmatory FT4 and TSH levels between cases with TCH and PCH.[35,37] In the current study, the initial NST and confirmatory TSH levels in the TCH group were significantly lower than those in the PCH group, but there was no difference in the FT4 between the…”
ResultInfluentialNatural History and Management of Congenital Hypothyroidism with in situ Thyroid Gland
Castanet, M., Goischke, A., Léger, J., Thalassinos, C., Rodrigue, D., Cabrol, S., Zenaty, D., al-Harbi, M., Polak, M., Czernichow, P., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000362234 · Cited by 24
Sánchez, A. R., Guinduláin, M. J. C., Merillas, M. A., Segura, S. A., Navarro, J. C. M., & Arnao, M. D. R. (2019) · Anales de Pediatría · doi:10.1016/j.anpedi.2018.11.002 · Cited by 32
Congenital hypothyroidism: etiology and growth-development outcome.
Dalili, S., Rezvani, S. M., Dalili, H., Mohtasham‐Amiri, Z., Mohammadi, H., Kesh, S. A., Novin, M. H., Medghalchi, A., & Gholamnezhad, H. (2014) · PubMed · Cited by 28
A Systematic Review on the Risk Factors of Congenital Hypothyroidism
Hashemipour, M., Samei, P., Kelishadi, R., Hovsepian, S., & Zavareh, N. H. T. (2019) · Journal of Pediatrics Review · doi:10.32598/jpr.7.4.199 · Cited by 23
“Details of all selected studies were presented in Table 1 (5, 8, 9, 12-67).”
BackgroundHabib, A., Shojazadeh, A., Molayemat, M., Habib, A., Jeddi, M., Arabsolghar, R., Nahas, M., Rahimi, N., & Ardekani, F. M. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02729-6 · Cited by 22
Congenital Hypothyroidism: Role of Nuclear Medicine
Keller, I., Léger, J., Sergent-Alaoui, A., & de Labriolle-Vaylet, C. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.10.005 · Cited by 21
Özer, Y., Anık, A., Sayılı, U., Tercan, U., Sevim, R. D., Güneş, S., Pirimoğlu, M. B., Elmaoğulları, S., Dündar, İ., Ökdemir, D., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02348-9 · Cited by 20
“High thyroglobulin levels and goiter in the TCH group may result from defects in iodine metabolism [24, 35].”
BackgroundResultInfluentialGoldis, M., Waldman, L., Mărginean, O., Rosenberg, H. K., & Rapaport, R. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.02.005 · Cited by 20
Epidemiology of Congenital Hypothyroidism
Olivieri, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_6 · Cited by 19
“A minority of cases had mutations in the genes commonly linked to mild forms of CH [ 46 ].”
BackgroundUthayaseelan, K., Kadari, M., Subhan, M., Parel, N. S., Krishna, P. V., Gupta, A., & Uthayaseelan, K. (2022) · Cureus · doi:10.7759/cureus.24669 · Cited by 23
“On the other hand, an ectopic thyroid gland suggests the possibility of transient hypothyroidism [48].”
BackgroundBarry, Y., MANDEREAU, L., Bonaldi, C., Cheillan, D., Coutant, R., Léger, J., & Regnault, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab854 · Cited by 17
Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism
Kara, C., Mammadova, J., Abur, Ü., Gümüşkaptan, Ç., Güllü, E. İ., Dağdemir, A., & Aydın, M. (2023) · European Thyroid Journal · doi:10.1530/etj-22-0212 · Cited by 18
Intelligence Quotient at the Age of Six years of Iranian Children with Congenital Hypothyroidism
Rahmani, K., Yarahmadi, S., Etemad, K., Mehrabi, Y., Aghang, N., Koosha, A., & Soori, H. (2017) · Indian Pediatrics · doi:10.1007/s13312-018-1243-2 · Cited by 19
“In addition to the genetic factors, age, sex and SES are considered most important confounders when we compare the difference between the IQ of CH cases and healthy children [17-19].”
BackgroundHiguchi, S., & Hasegawa, Y. (2019) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.28.127 · Cited by 15
“Although in this study, there were no significant differences in the thyroid gland size and position between P-CH and T-CH patients, abnormal thyroid gland morphology was found to be associated with P-CH, as reported in previous studies (1, 2, 9, 10).”
ResultTuli, G., Munarin, J., & SANCTIS, L. D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235583 · Cited by 16
“[4] 2013 84 67% Same clinical outcome in patients with screening TSH values < 20 and >20 mcUI/mL.”
BackgroundThe evaluation of transient hypothyroidism in patients diagnosedwith congenital hypothyroidism
Kendırcı, H. N. P., Aycan, Z., Sağsak, E., Keskın, M., & Çetinkaya, S. Ç. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1404-109 · Cited by 15
Jaruratanasirikul, S., Piriyaphan, J., Saengkaew, T., Janjindamai, W., & Sriplung, H. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0340 · Cited by 15
Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update
Vigone, M. C., Frenna, M. D., & Weber, G. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0288-5 · Cited by 16
“1 3 incidence of CH confirmed at birth (permanent + transient) in the Italian population showed a clear-cut prevalence of functional defects with a eutopic thyroid (2/3) over dysgenetic ones (1/3) [17, 20, 21].”
BackgroundSelf-citationEndocrine Diseases and Disorders of Thyroid Function in Newborns
Ghirri, P., Balsamo, A., Ciantelli, M., Cavarzere, P., Cicognani, A., Boldrini, A., & Cassio, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-29489-6_259 · Cited by 13
Connelly, K. J., & LAFRANCHI, S. H. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.897607 · Cited by 14
“Subsequently, additional missense and splice-site mutations in DUOX2 have been associated with a wide spectrum of CH phenotypes, varying from mild to severe forms [18].”
BackgroundInfluentialMatejek, N., Tittel, S. R., Haberland, H., Rohrer, T. R., Busemann, E.-M., Jorch, N., Schwab, K., Woelfle, J., Holl, R. W., & Bettendorf, M. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04031-0 · Cited by 14
McNally, R., Jones, J. H., Shaikh, M. G., Donaldson, M., Blakey, K., & Cheetham, T. D. (2020) · Thyroid · doi:10.1089/thy.2020.0005 · Cited by 12
“Many babies with a gland in situ have transient CHT, but this does not preclude an underlying molecular defect (7).”
BackgroundScavone, M., Carboni, E., Stefanelli, E., Romano, G., Vero, A., Giancotti, L., MINIERO, R., & Talarico, V. (2018) · Indian Pediatrics · doi:10.1007/s13312-018-1442-x · Cited by 12
Al-Qahtani, M. H. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1838480 · Cited by 15
“LOW levothyroxine dose requirement less than 2mcg/ kg/day at age of 3 years is considered a very good indicator for successful discontinuation of the treatment [72].”
BackgroundNagasaki, K., Sato, H., Sasaki, S., Nyuzuki, H., Shibata, N., Sawano, K., Hiroshima, S., & Asami, T. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7020027 · Cited by 11
Mard‐Soltani, M., Rasaee, M. J., Khalili, S., Sheikhi, A., Hedayati, M., Ghaderi-Zefrehi, H., & Alasvand, M. (2018) · PubMed · Cited by 11
Diagnosis and follow-up of patients with congenital hypothyroidism detected by neonatal screening
Sánchez, A. R., Guinduláin, M. J. C., Merillas, M. A., Segura, S. A., Navarro, J. C. M., & Arnao, M. D. R. (2019) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2018.11.011 · Cited by 15
“The diagnosis ought to be re-evaluated in children with CHT and a normally positioned thyroid at the time of initial diagnosis, and in children with CHT of unknown aetiology.(36,37) Re-evaluation should also be contemplated in patients in whom the diagnosis was not confirmed (by scintigraphy) at the time treatment was…”
BackgroundMehran, L., Azizi, F., Mousapour, P., Cheraghi, L., Yarahmadi, S., Amirshekari, G., & Khalili, D. (2021) · Endocrine · doi:10.1007/s12020-021-02641-0 · Cited by 12
de Matos, D. M., Ramalho, R. J. R., Carvalho, B. M., Almeida, M. A. C. T., Passos, L. F. D., Vasconcelos, T. T. S., de Melo, E. V., Oliveira, C. R. P., Santos, E. G., Rezende, K. F., et al. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000189 · Cited by 11
Rectal levothyroxine for the treatment of hypothyroidism: a case study
Ybarra, M., dos Santos, T. J., Pinheiro, C. T. C., Dichtchekenian, V., & Damiani, D. (2018) · PEDIATRICS · doi:10.1542/peds.2017-3317 · Cited by 10
Lee, S. H., Lee, H. G., Yang, E. M., & Kim, C. J. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244260.130 · Cited by 9
Yamamura, H., Kokumai, T., Furuya, A., Suzuki, S., Tanahashi, Y., & Azuma, H. (2020) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.29.143 · Cited by 9
“In contrast, others reported that there was no significant difference between P-CH and T-CH in the initial TFTs (8).”
ResultFlores-Robles, C. M., Coronado-Zarco, I. A., Ortega-González, C., Arreóla-Ramírez, G., & Reyes-Muñoz, E. (2018) · Perinatología y Reproducción Humana · doi:10.1016/j.rprh.2018.04.003 · Cited by 16
Vincenzi, G., Petralia, I. T., Abbate, M. T. A., & Vigone, M. C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0019 · Cited by 10
“Over time, as the incidence of ‘ mild ’ forms of CH has been increasing, so has the incidence of transient forms (11).”
Self-citationGorini, F., Coi, A., Pierini, A., Assanta, N., Bottoni, A., & Santoro, M. C. (2024) · Children · doi:10.3390/children11050513 · Cited by 10
“…strategies and the introduction of progressively lower cutoffs of TSH to improve sensitivity for CH (i.e., from above 20–25 mIU/L to above 6–10 mIU/L), a greater number of mild forms of CH (some of which are transient) have been reported to be associated with a eutopic thyroid gland [37–39].”
BackgroundChen, S., Yang, B., Li, J.-Y., Xu, P., & Wang, F. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0733 · Cited by 8
Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia
Mitchell, M. L., Hsu, H.-W., & Sahai, I. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000028 · Cited by 8
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Self-citationTuli, G., Munarin, J., Topalli, K., Pavanello, E., & SANCTIS, L. D. (2023) · Thyroid · doi:10.1089/thy.2022.0495 · Cited by 8
“10 11–21 The latter category has a risk of de-velopingCHcomparedwithinfantsbornattermduetomultiplefactors.”
Congenital Hypothyroidism: 8-Year Experience Using 2 Newborn Screens in Alabama
Pitts, L. N., McCormick, W. L., & Mick, G. J. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501395 · Cited by 8
DUOX1 and DUOX2, DUOXA1 and DUOXA2
Miot, F., & Deken, X. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_14 · Cited by 8
Predictive factors of permanent versus transient congenital hypothyroidism: a pragmatic cohort study
Dermitzaki, N., Giapros, V. I., Deligeorgopoulou, M., Tsinopoulou, V. R., Kotanidou, E. P., Baltogianni, M. S., Balomenou, F., & Serbis, A. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2448126.063 · Cited by 6
“The mean TSH concentration was significantly higher in the PCH group, consistent with previous reports [2,18,19,24]; however, other authors have reported that discrimination based on TSH concentrations is unreliable, as overlap between the 2 groups is often observed [3,4,25].”
Mansour, C., Ouarezki, Y., Jones, J. H., Green, M., Stenhouse, E., Irwin, G., Hermanns, P., Pohlenz, J., & Donaldson, M. (2020) · BJR|Open · doi:10.1259/bjro.20200001 · Cited by 6
Spatial Distribution of Congenital Hypothyroidism
Mahaki, B., Mehrnejat, N., Zabihi, M., Dalvi, M., & Kazemitabaee, M. (2021) · Archives of Iranian Medicine · doi:10.34172/aim.2021.90 · Cited by 6
Detección precoz de alteraciones endocrinas
Arnao, M. D. R., Sánchez, A. R., & Dulín, E. (2013) · Cited by 10
Etiological Evaluation of Congenital Hypothyroidism Cases
Anık, A., Berber, İ. B. B., Ünüvar, T., & Anık, A. (2020) · Journal of Dr Behcet Uz Children s Hospital · doi:10.5222/buchd.2020.38243 · Cited by 5
Ortolano, R., Cantarelli, E., Baronio, F., Assirelli, V., Candela, E., Mastrangelo, C., Vissani, S., Alqaisi, R. S., Lanari, M., & Cassio, A. (2024) · Children · doi:10.3390/children11091136 · Cited by 6
“This choice was supported by our clinical experience and previous report of a major incidence of permanent CH in smaller thyroid glands [13].”
Knowns and unknowns about congenital hypothyroidism: 2022 update
Itonaga, T., Hasegawa, Y., Higuchi, S., Satoh, M., Sawada, H., Shimura, K., Takahashi, I., Takubo, N., & Nagasaki, K. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0016 · Cited by 7
“Second, the TSH level at diagnosis also reportedly had a predictive value (76, 83), although other reports showed no significant difference in TSH levels between P-CH and T-CH (73–75, 77, 80, 84, 85, 87, 89).”
Bontemps, S. H., Legagneur, C., Guéant‐Rodriguez, R., Rémen, T., Luc, A., & Renard, É. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0101 · Cited by 7
The Role of 123I Imaging in the Evaluation of Infants with Mild Congenital Hypothyroidism
Graber, E., Regelmann, M. O., Annunziato, R. A., Macháč, J., & Rapaport, R. (2014) · Hormone Research in Paediatrics · doi:10.1159/000367992 · Cited by 5
Incidence and Risk Factor of Permanent Hypothyroidism in Preterm Infants
Chung, M. L. (2017) · Journal of Neonatal Biology · doi:10.4172/2167-0897.1000254 · Cited by 4
“Therefore, in the meantime, there have been many efforts to predict the permanence of thyroid dysfunction [24-28].”
BackgroundÉpidémiologie de l’hypothyroïdie congénitale en France : données récentes
Léger, J. (2019) · Biologie Aujourd hui · doi:10.1051/jbio/2019005 · Cited by 5
Use of Tc‐99 m thyroid scans in borderline congenital hypothyroidism
Oren, A., Wang, M. K., Brnjac, L., Mahmud, F. H., & Palmert, M. R. (2015) · Clinical Endocrinology · doi:10.1111/cen.12807 · Cited by 4
Cosmo, C. D., & Tonacchera, M. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_11 · Cited by 4
Evaluation of Transient or Permanent Congenital Hypothyroidism
Kurtoğlu, S., Baştuğ, O., & Özdemir, A. (2023) · Journal of Clinical Practice and Research · doi:10.14744/cpr.2023.32042 · Cited by 4
Kurnaz, E., Türkyılmaz, A., Yaralı, O., Donmez, A. S., & Çayır, A. (2024) · Hormone Research in Paediatrics · doi:10.1159/000541898 · Cited by 3
“…increase in LT4 dosage over time due to a rise in TSH levels during treatment, or (iii) exhibited low FT4 and/or elevated TSH levels upon re-evaluation after 2 – 3 years of age following treatment withdrawal (with TSH > 15 μ U/mL at the 1st month or > 10 μ U/mL at or after the 3rd month) [15, 16].”
Metadata
- Authors
- Rabbiosi, S., Vigone, M. C., Cortinovis, F., Zamproni, I., Fugazzola, L., Persani, L., Corbetta, C., Chiumello, G., & Weber, G.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Department of Pediatrics (S.R., M.C.V., F.C., G.C., G.W.), 20132 Milan, Italy
- University of Milan (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- Corresponding author
- Rabbiosi, Sarah
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-04-01
- Volume
- 98
- Issue
- 4
- Pages
- 1395-1402
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2051249595
- Cited by
- 131
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 11 · 2018: 16 · 2017: 8 · 2016: 12 · 2015: 9 · 2014: 16 · 2013: 4
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, transient hypothyroidism, permanent hypothyroidism, hyperthyrotropinemia, TSH receptor mutations, preterm birth, thyroid hypoplasia, prognostic factors, thyroid function tests, thyroid ultrasound
- MeSH terms
- Child, Child, Preschool, Congenital Hypothyroidism, Female, Follow-Up Studies, Humans, Infant, Newborn, Infant, Premature, Male, Prognosis, Retrospective Studies, Thyroid Function Tests, Thyroid Gland, Thyroxine, Ultrasonography, Cohort Studies, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.